MEDDRIVE

Serial Number 90642095
Registration 7062823
700

Registration Progress

Application Filed
Apr 13, 2021
Under Examination
Apr 12, 2022
Approved for Publication
Feb 15, 2022
Published for Opposition
Feb 15, 2022
Registered
May 23, 2023

Trademark Image

MEDDRIVE

Basic Information

Serial Number
90642095
Registration Number
7062823
Filing Date
April 13, 2021
Registration Date
May 23, 2023
Published for Opposition
February 15, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 23, 2023
Registration
Registered
Classes
035 036

Rights Holder

Prime Therapeutics LLC

16
Address
2900 Ames Crossing Road, Suite 200
Eagan, MN 55121

Ownership History

Prime Therapeutics LLC

Original Applicant
16
Eagan, MN

Prime Therapeutics LLC

Owner at Publication
16
Eagan, MN

Prime Therapeutics LLC

Original Registrant
16
Eagan, MN

Legal Representation

Attorney
Felicia J. Boyd

USPTO Deadlines

Next Deadline
1296 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-05-23)
Due Date
May 23, 2029
Grace Period Ends
November 23, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Jul 12, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 12, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 12, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 12, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 12, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 21, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 21, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 21, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 21, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 21, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 23, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 23, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 18, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 17, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 13, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 13, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 27, 2023 IUAF S USE AMENDMENT FILED Loading...
Mar 27, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 14, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 12, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 12, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 12, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 12, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 12, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 11, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 10, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 10, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 7, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 7, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 7, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 3, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 20, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 16, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Drug utilization review services and drug formulary management services; healthcare utilization review services; pharmaceutical cost management services; medical cost management; providing business intelligence services in the field of pharmacy benefit management; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of data pertaining to pharmaceuticals and consumer behavior for business purposes; providing business management information in connection with consulting and advisory services to the healthcare industry in the fields of prescription drug savings and reducing out-of-pocket costs and expenses for prescriptions; business administration services, namely, negotiating contracts with drug manufacturers to enable participant members of pharmacy benefit management clients to obtain discounts and rebates on pharmaceuticals; medical cost management consulting in the field of drug therapies, specifically, site of care and administration of drugs
First Use Anywhere: May 26, 2021
First Use in Commerce: May 26, 2021
Class 036
Pharmacy benefit management services
First Use Anywhere: May 26, 2021
First Use in Commerce: May 26, 2021

Additional Information

Pseudo Mark
MED DRIVE

Classification

International Classes
035 036